Tenax Cost Of Revenue from 2010 to 2024

TENX Stock  USD 5.88  0.13  2.16%   
Tenax Therapeutics Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue will likely drop to 7,192 in 2024. During the period from 2010 to 2024, Tenax Therapeutics Cost Of Revenue regression line of annual values had r-squared of  0.15 and arithmetic mean of  76,030. View All Fundamentals
 
Cost Of Revenue  
First Reported
2000-06-30
Previous Quarter
4.7 K
Current Value
1000
Quarterly Volatility
834.6 K
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tenax Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tenax Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.2 K, Other Operating Expenses of 8.4 M or Research Development of 3.6 M, as well as many indicators such as Price To Sales Ratio of 141.3 K, Dividend Yield of 3.31 or PTB Ratio of 0.71. Tenax financial statements analysis is a perfect complement when working with Tenax Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tenax Therapeutics Correlation against competitors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.

Latest Tenax Therapeutics' Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Tenax Therapeutics over the last few years. Cost of Revenue is found on Tenax Therapeutics income statement and represents the costs associated with goods and services Tenax Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Tenax Therapeutics' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tenax Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

Tenax Cost Of Revenue Regression Statistics

Arithmetic Mean76,030
Geometric Mean43,316
Coefficient Of Variation84.57
Mean Deviation55,318
Median100,000
Standard Deviation64,299
Sample Variance4.1B
Range212K
R-Value(0.39)
Mean Square Error3.8B
R-Squared0.15
Significance0.16
Slope(5,544)
Total Sum of Squares57.9B

Tenax Cost Of Revenue History

2024 7191.5
2023 7570.0
2022113.3 K
2021109 K
2020114.7 K
2019107.3 K
2018 9015.0

About Tenax Therapeutics Financial Statements

Tenax Therapeutics investors use historical fundamental indicators, such as Tenax Therapeutics' Cost Of Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tenax Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue7.6 K7.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.